The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma
| Image |  |
|---|---|
| Description | scientific article published on 4 August 2010 |
| Author/s |
author: Masatoshi Kudo |
| Publication date | August 4, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |